Business Context and Reporting Period
This Form 8-K is a current report filed by TNF Pharmaceuticals, Inc. (TNFA) on April 10, 2025. The filing addresses corporate governance matters regarding the scheduling of the 2025 Annual Meeting of Stockholders and the deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance notifications and contains no financial performance data.
Material Changes
The primary material change reported is the rescheduling of the 2025 Annual Meeting of Stockholders. The meeting will now be held virtually on May 20, 2025, at 10:00 a.m. Eastern Time. This date represents a change of more than 30 days from the anniversary of the 2024 Annual Meeting, triggering specific disclosure requirements for shareholder proposal deadlines.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business operations in this filing. The document focuses on procedural requirements for shareholders wishing to submit proposals or nominate directors. Key deadlines established include:
- April 18, 2025: Deadline for receiving Rule 14a-8 proposals for inclusion in proxy materials.
- April 18, 2025: Deadline for written notice of business proposals or director nominations outside of Rule 14a-8.
- April 18, 2025: Deadline for notice under universal proxy rules (Rule 14a-19) for shareholders soliciting proxies for director nominees other than the Company's nominees.
Key Facts for Investor Verification
- Verify the virtual meeting date of May 20, 2025, and the 10:00 a.m. ET start time.
- Confirm the April 18, 2025, deadline for submitting shareholder proposals and director nominations to the Corporate Secretary at 1185 Avenue of the Americas, New York, NY 10036.
- Note that the filing does not contain financial results; investors should refer to the most recent 10-Q or 10-K for financial data.